Literature DB >> 1277214

Approaches to the pharmacokinetics of cyclophosphamide (NSC 26271): Quantitation of metabolites.

I Jardine, R Brundrett, M Colvin, C Fenselau.   

Abstract

Recent evidence has implicated phosphoramide mustard as a highly active metabolite of cyclophosphamide (CP). This compound has been shown to be produced from CP both in vitro and in vivo. To further study the role of this active metabolite we have devised methods to quantitate the compound in human serum and urine using gas chromatography-chemical ionization mass spectrometry. Tetradeuterated phosphoramide mustard has been synthesized and is used as an internal standard. CP and nor-nitrogen mustard have also been quantitated in human samples using analogous tetradeuterated internal standards.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1277214

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  4 in total

1.  A procedure for monitoring cyclophosphamide and isophosphamide in biological samples.

Authors:  B Whiting; S H Miller; B Caddy
Journal:  Br J Clin Pharmacol       Date:  1978-10       Impact factor: 4.335

2.  Preclinical pharmacokinetics and stability of isophosphoramide mustard.

Authors:  J J Zheng; K K Chan; F Muggia
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

3.  The disposition of cyclophosphamide in a group of myeloma patients.

Authors:  V Bramwell; R T Calvert; G Edwards; H Scarffe; D Crowther
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Pharmacokinetics of intravenous cyclophosphamide in man, estimated by gas-liquid chromatography.

Authors:  F D Juma; H J Rogers; J R Trounce; I D Bradbrook
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.